TY - JOUR AU - Sankaranarayanan, R. AU - Kirkwood, G. AU - Visweswariah, R. AU - Fox, D. J. PY - 2015 DA - 2015// TI - How does chronic atrial fibrillation influence mortality in the modern treatment era? JO - Curr Cardiol Rev VL - 11 UR - https://doi.org/10.2174/1573403X10666140902143020 DO - 10.2174/1573403X10666140902143020 ID - Sankaranarayanan2015 ER - TY - JOUR AU - Connolly, S. J. AU - Ezekowitz, M. D. AU - Yusuf, S. AU - Eikelboom, J. AU - Oldgren, J. AU - Parekh, A. PY - 2009 DA - 2009// TI - Dabigatran versus warfarin in patients with atrial fibrillation JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0905561 DO - 10.1056/NEJMoa0905561 ID - Connolly2009 ER - TY - JOUR AU - Lip, G. Y. AU - Clemens, A. AU - Noack, H. AU - Ferreira, J. AU - Connolly, S. J. AU - Yusuf, S. PY - 2014 DA - 2014// TI - Patient outcomes using the European label for dabigatran. A post-hoc analysis from the RE-LY database JO - Thromb Haemost VL - 111 UR - https://doi.org/10.1160/TH13-09-0734 DO - 10.1160/TH13-09-0734 ID - Lip2014 ER - TY - JOUR AU - Granger, C. B. AU - Alexander, J. H. AU - McMurray, J. J. AU - Lopes, R. D. AU - Hylek, E. M. AU - Hanna, M. PY - 2011 DA - 2011// TI - Apixaban versus warfarin in patients with atrial fibrillation JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1107039 DO - 10.1056/NEJMoa1107039 ID - Granger2011 ER - TY - JOUR AU - Patel, M. R. AU - Mahaffey, K. W. AU - Garg, J. AU - Pan, G. AU - Singer, D. E. AU - Hacke, W. PY - 2011 DA - 2011// TI - Rivaroxaban versus warfarin in nonvalvular atrial fibrillation JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1009638 DO - 10.1056/NEJMoa1009638 ID - Patel2011 ER - TY - JOUR AU - Giugliano, R. P. AU - Ruff, C. T. AU - Braunwald, E. AU - Murphy, S. A. AU - Wiviott, S. D. AU - Halperin, J. L. PY - 2013 DA - 2013// TI - Edoxaban versus warfarin in patients with atrial fibrillation JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1310907 DO - 10.1056/NEJMoa1310907 ID - Giugliano2013 ER - TY - JOUR AU - Kirchhof, P. AU - Benussi, S. AU - Kotecha, D. AU - Ahlsson, A. AU - Atar, D. AU - Casadei, B. PY - 2016 DA - 2016// TI - 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS JO - Eur Heart J VL - 37 UR - https://doi.org/10.1093/eurheartj/ehw210 DO - 10.1093/eurheartj/ehw210 ID - Kirchhof2016 ER - TY - STD TI - European Medicines Agency. Lixiana: summary of product characteristics 2015. ID - ref8 ER - TY - JOUR AU - Huisman, M. V. AU - Rothman, K. J. AU - Paquette, M. AU - Teutsch, C. AU - Diener, H. C. AU - Dubner, S. J. PY - 2017 DA - 2017// TI - The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2 JO - J Am Coll Cardiol VL - 69 UR - https://doi.org/10.1016/j.jacc.2016.11.061 DO - 10.1016/j.jacc.2016.11.061 ID - Huisman2017 ER - TY - JOUR AU - Steinberg, B. A. AU - Simon, D. N. AU - Thomas, L. AU - Ansell, J. AU - Fonarow, G. C. AU - Gersh, B. J. PY - 2017 DA - 2017// TI - Management of Major Bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist Oral anticoagulants compared with warfarin in clinical practice (from phase II of the outcomes registry for better informed treatment of atrial fibrillation [ORBIT-AF II]) JO - Am J Cardiol VL - 119 UR - https://doi.org/10.1016/j.amjcard.2017.02.015 DO - 10.1016/j.amjcard.2017.02.015 ID - Steinberg2017 ER - TY - JOUR AU - Camm, A. J. AU - Amarenco, P. AU - Haas, S. AU - Hess, S. AU - Kirchhof, P. AU - Eickels, M. PY - 2014 DA - 2014// TI - XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation JO - Vasc Health Risk Manag VL - 10 UR - https://doi.org/10.2147/VHRM.S63298 DO - 10.2147/VHRM.S63298 ID - Camm2014 ER - TY - JOUR AU - Camm, A. J. AU - Accetta, G. AU - Ambrosio, G. AU - Atar, D. AU - Bassand, J. P. AU - Berge, E. PY - 2017 DA - 2017// TI - Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation JO - Heart. VL - 103 UR - https://doi.org/10.1136/heartjnl-2016-309832 DO - 10.1136/heartjnl-2016-309832 ID - Camm2017 ER - TY - JOUR AU - Eikelboom, J. W. AU - Weitz, J. I. PY - 2015 DA - 2015// TI - ‘Realworld’ use of non-vitamin K antagonist oral anticoagulants (NOACs): lessons from the Dresden NOAC registry JO - Thromb Haemost VL - 113 UR - https://doi.org/10.1160/TH15-02-0158 DO - 10.1160/TH15-02-0158 ID - Eikelboom2015 ER - TY - JOUR AU - Hanon, O. AU - Vidal, J. S. AU - Heuzey, J. Y. AU - Kirchhof, P. AU - Caterina, R. AU - Schmitt, J. PY - 2017 DA - 2017// TI - Oral anticoagulant use in octogenarian European patients with atrial fibrillation: a subanalysis of PREFER in AF JO - Int J Cardiol VL - 232 UR - https://doi.org/10.1016/j.ijcard.2017.01.046 DO - 10.1016/j.ijcard.2017.01.046 ID - Hanon2017 ER - TY - JOUR AU - Boriani, G. AU - Proietti, M. AU - Laroche, C. AU - Diemberger, I. AU - Popescu, M. I. AU - Riahi, S. PY - 2018 DA - 2018// TI - Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational research Programme on atrial fibrillation (EORP-AF) pilot general registry JO - Int J Cardiol VL - 271 UR - https://doi.org/10.1016/j.ijcard.2018.05.034 DO - 10.1016/j.ijcard.2018.05.034 ID - Boriani2018 ER - TY - JOUR AU - Pottegard, A. AU - Grove, E. L. AU - Hellfritzsch, M. PY - 2018 DA - 2018// TI - Use of direct oral anticoagulants in the first year after market entry of edoxaban: a Danish nationwide drug utilization study JO - Pharmacoepidemiol Drug Saf VL - 27 UR - https://doi.org/10.1002/pds.4350 DO - 10.1002/pds.4350 ID - Pottegard2018 ER - TY - JOUR AU - Coleman, C. I. AU - Antz, M. AU - Bowrin, K. AU - Evers, T. AU - Simard, E. P. AU - Bonnemeier, H. PY - 2016 DA - 2016// TI - Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study JO - Curr Med Res Opin VL - 32 UR - https://doi.org/10.1080/03007995.2016.1237937 DO - 10.1080/03007995.2016.1237937 ID - Coleman2016 ER - TY - JOUR AU - Coleman, C. I. AU - Antz, M. AU - Ehlken, B. AU - Evers, T. PY - 2016 DA - 2016// TI - REal-LIfe evidence of stroke prevention in patients with atrial fibrillation--the RELIEF study JO - Int J Cardiol VL - 203 UR - https://doi.org/10.1016/j.ijcard.2015.09.037 DO - 10.1016/j.ijcard.2015.09.037 ID - Coleman2016 ER - TY - JOUR AU - Deitelzweig, S. AU - Luo, X. AU - Gupta, K. AU - Trocio, J. AU - Mardekian, J. AU - Curtice, T. PY - 2017 DA - 2017// TI - Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients JO - Curr Med Res Opin VL - 33 UR - https://doi.org/10.1080/03007995.2017.1334638 DO - 10.1080/03007995.2017.1334638 ID - Deitelzweig2017 ER - TY - JOUR AU - Serebruany, V. AU - Cherepanov, V. AU - Fortmann, S. AU - Kim, M. H. PY - 2017 DA - 2017// TI - Mortality and oral anticoagulants in the Food and Drug Administration adverse event reporting system JO - Open Heart VL - 4 UR - https://doi.org/10.1136/openhrt-2017-000629 DO - 10.1136/openhrt-2017-000629 ID - Serebruany2017 ER - TY - JOUR AU - Caterina, R. AU - Kelly, P. AU - Monteiro, P. AU - Deharo, J. C. AU - Asmundis, C. AU - López-de-Sá, E. PY - 2019 DA - 2019// TI - Design and rationale of the edoxaban treatment in routiNe clinical prActice for patients with atrial fibrillation in Europe (ETNA-AF-Europe) study JO - J Cardiovasc Med (Hagerstown) VL - 20 UR - https://doi.org/10.2459/JCM.0000000000000737 DO - 10.2459/JCM.0000000000000737 ID - Caterina2019 ER - TY - JOUR AU - Kotecha, D. AU - Bax, J. J. AU - Carrera, C. AU - Casadei, B. AU - Merkely, B. AU - Anker, S. D. PY - 2018 DA - 2018// TI - Roadmap for cardiovascular education across the European Society of Cardiology: inspiring better knowledge and skills, now and for the future JO - Eur Heart J VL - 40 UR - https://doi.org/10.1093/eurheartj/ehy058 DO - 10.1093/eurheartj/ehy058 ID - Kotecha2018 ER - TY - JOUR AU - Nielsen, P. B. AU - Skjoth, F. AU - Sogaard, M. AU - Kjaeldgaard, J. N. AU - Lip, G. Y. AU - Larsen, T. B. PY - 2017 DA - 2017// TI - Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study JO - Bmj. VL - 356 UR - https://doi.org/10.1136/bmj.j510 DO - 10.1136/bmj.j510 ID - Nielsen2017 ER - TY - JOUR AU - Barra, M. E. AU - Fanikos, J. AU - Connors, J. M. AU - Sylvester, K. W. AU - Piazza, G. AU - Goldhaber, S. Z. PY - 2016 DA - 2016// TI - Evaluation of dose-reduced direct Oral anticoagulant therapy JO - Am J Med VL - 129 UR - https://doi.org/10.1016/j.amjmed.2016.05.041 DO - 10.1016/j.amjmed.2016.05.041 ID - Barra2016 ER - TY - JOUR AU - Lavoie, K. AU - Turgeon, M. H. AU - Brais, C. AU - Larochelle, J. AU - Blais, L. AU - Farand, P. PY - 2016 DA - 2016// TI - Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation JO - J Atr Fibrillation VL - 9 UR - https://doi.org/10.4022/jafib.1478 DO - 10.4022/jafib.1478 ID - Lavoie2016 ER - TY - JOUR AU - Yao, X. AU - Shah, N. D. AU - Sangaralingham, L. R. AU - Gersh, B. J. AU - Noseworthy, P. A. PY - 2017 DA - 2017// TI - Non-vitamin K antagonist Oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction JO - J Am Coll Cardiol VL - 69 UR - https://doi.org/10.1016/j.jacc.2017.03.600 DO - 10.1016/j.jacc.2017.03.600 ID - Yao2017 ER - TY - JOUR AU - Yamashita, T. AU - Koretsune, Y. AU - Yang, Y. AU - Chen, S. A. AU - Chung, N. AU - Shimada, Y. J. PY - 2016 DA - 2016// TI - Edoxaban vs. warfarin in east Asian patients with atrial fibrillation- an ENGAGE AF-TIMI 48 subanalysis JO - Circ J VL - 80 UR - https://doi.org/10.1253/circj.CJ-15-1082 DO - 10.1253/circj.CJ-15-1082 ID - Yamashita2016 ER - TY - JOUR AU - Steffel, J. AU - Verhamme, P. AU - Potpara, T. S. AU - Albaladejo, P. AU - Antz, M. AU - Desteghe, L. PY - 2018 DA - 2018// TI - The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation JO - Eur Heart J VL - 39 UR - https://doi.org/10.1093/eurheartj/ehy136 DO - 10.1093/eurheartj/ehy136 ID - Steffel2018 ER -